Difference between revisions of "SwitchAntipsychotics"
From Psychiatrienet
Line 39: | Line 39: | ||
| afk23 = Mz | med23 = Zuclopenthixol_MA | | | afk23 = Mz | med23 = Zuclopenthixol_MA | | ||
}} | }} | ||
− | '''ER''' = '' | + | '''ER''' = ''extended release (long + super + ultra long acting)''', ''LA''' = ''long acting'', '''MA''' = ''medium acting'', '''UC''' = ''under construction''<br /> |
(part of www.psychiatrienet.nl) | (part of www.psychiatrienet.nl) | ||
[[category:Switchtable]] | [[category:Switchtable]] |
Revision as of 13:18, 18 March 2022
Switching Antipsychotics (part of www.psychiatrienet.nl)
To see the consequences of a switch between antipsychotics click in the crosstable below:
the switch is made "from" (vertical) "to" (horizontal).
During switching: don't reduce anticholinergics; consider adding oxazepam. Read: General considerations concerning switching antipsychotics.
Rest AP = Chlorprothixene, Flupentixol, Fluphenazine Loxapine, Pericyazine, Perphenazine,Promazine, Trifluoperazine, Ziprasidone, Zuclopentixol.
Partial agonist new = Aripiprazole, Brexpiprazole, Cariprazine.
ER = extended release (long + super + ultra long acting), LA = long acting, MA = medium acting, UC = under construction
(part of www.psychiatrienet.nl)